ES2170771T3 - Atenuacion de un epitopo inmunodominante de un antigeno para su utilizacion en vacunas e inmunoterapias para vegetales, animales y humanos. - Google Patents
Atenuacion de un epitopo inmunodominante de un antigeno para su utilizacion en vacunas e inmunoterapias para vegetales, animales y humanos.Info
- Publication number
- ES2170771T3 ES2170771T3 ES94925937T ES94925937T ES2170771T3 ES 2170771 T3 ES2170771 T3 ES 2170771T3 ES 94925937 T ES94925937 T ES 94925937T ES 94925937 T ES94925937 T ES 94925937T ES 2170771 T3 ES2170771 T3 ES 2170771T3
- Authority
- ES
- Spain
- Prior art keywords
- epithope
- immunodominant
- antigen
- immunotherapies
- vaccines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 239000000427 antigen Substances 0.000 title abstract 2
- 102000036639 antigens Human genes 0.000 title abstract 2
- 108091007433 antigens Proteins 0.000 title abstract 2
- 238000009169 immunotherapy Methods 0.000 title 1
- 235000013311 vegetables Nutrition 0.000 title 1
- 244000052769 pathogen Species 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- AIDS & HIV (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
LA INVENCION SUMINISTRA UNA VACUNA QUE PUEDE ADMINISTRARSE A UN MAMIFERO PARA PROVOCAR LA INMUNO-PROTECCION EN EL MAMIFERO CONTRA UN ORGANISMO PATOGENICO QUE TENGA UN EPITOPO INMUNODOMINANTE. LA VACUNA INCLUYE UNA FORMA MODIFICADA DEL ANTIGENO EN EL CUAL SE LOCALIZA EL EPITOPO INMUNODOMINANTE. EN ESTA FORMA MODIFICADA, EL EPITOPO INMUNODOMINANTE ES INMUNOHUMECTADO POR CUALQUIERA DE ENTRE UN NUMERO DE TECNICAS. LOS EJEMPLOS DE TECNICAS DE INMUNO-HUMECTACION INCLUYE LA ADICION DE ZONAS DE GLICOSILACION N- ENLAZADAS, EL CAMBIO DE LA CARGA DE RED DEL EPITOPO Y LA SUSTITUCION CON UNA SECUENCIA TOLERADA. LA VACUNA TAMBIEN INCLUYE UN PORTADOR FARMACOLOGICAMENTE ACEPTABLE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/109,934 US5585250A (en) | 1993-08-20 | 1993-08-20 | Dampening of an immunodominant epitope of an antigen for use in plant, animal and human compositions and immunotherapies |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2170771T3 true ES2170771T3 (es) | 2002-08-16 |
Family
ID=22330363
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94925937T Expired - Lifetime ES2170771T3 (es) | 1993-08-20 | 1994-08-19 | Atenuacion de un epitopo inmunodominante de un antigeno para su utilizacion en vacunas e inmunoterapias para vegetales, animales y humanos. |
Country Status (11)
Country | Link |
---|---|
US (2) | US5585250A (es) |
EP (1) | EP0714444B1 (es) |
JP (2) | JP3851938B2 (es) |
AT (1) | ATE211767T1 (es) |
AU (1) | AU700786B2 (es) |
CA (2) | CA2623540A1 (es) |
DE (1) | DE69429625T2 (es) |
DK (1) | DK0714444T3 (es) |
ES (1) | ES2170771T3 (es) |
PT (1) | PT714444E (es) |
WO (1) | WO1995006124A1 (es) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5585250A (en) * | 1993-08-20 | 1996-12-17 | The United States Of America As Represented By The Department Of Health & Human Services | Dampening of an immunodominant epitope of an antigen for use in plant, animal and human compositions and immunotherapies |
EP0862584B1 (en) * | 1995-11-03 | 2004-12-22 | The Binding Site Limited | Production of antibodies |
US6642011B2 (en) * | 1998-04-15 | 2003-11-04 | Genencor International, Inc. | Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins |
US6936249B1 (en) * | 1998-04-15 | 2005-08-30 | Genencor International, Inc. | Proteins producing an altered immunogenic response and methods of making and using the same |
US6835550B1 (en) * | 1998-04-15 | 2004-12-28 | Genencor International, Inc. | Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins |
US20020182180A1 (en) * | 1998-05-29 | 2002-12-05 | Yutaro Kaneko | Method for inducing immunity to viruses |
ES2289824T3 (es) * | 1998-10-30 | 2008-02-01 | Novozymes A/S | Proteinas glicosiladas con alergenicidad reducida. |
US6759216B1 (en) * | 1998-11-06 | 2004-07-06 | Emory University | Glycosylated, low antigenicity low immunogenicity factor VIII |
US7078043B2 (en) | 1999-04-20 | 2006-07-18 | Medical Research Council | Malaria vaccine |
DE10055786A1 (de) * | 2000-11-10 | 2002-05-29 | Henkel Kgaa | Haftungsverstärker für monomerfreie reaktive Polyurethane |
PL356128A1 (en) | 1999-11-29 | 2004-06-14 | Henkel Kommanditgesellschaft Auf Aktien | Adhesion promoters for monomer-free reactive polyurethanes |
US6673580B2 (en) * | 2000-10-27 | 2004-01-06 | Genentech, Inc. | Identification and modification of immunodominant epitopes in polypeptides |
WO2004053100A2 (en) * | 2002-12-11 | 2004-06-24 | The Scripps Research Institute | Immunogenic mutant human immunodeficiency virus gp120 polypeptides, and methods of using same |
US7514539B2 (en) * | 2004-04-26 | 2009-04-07 | Centocor, Inc. | Epitope directed selection of antibodies to murine tissue factor |
US7790405B2 (en) * | 2004-04-26 | 2010-09-07 | Centocor, Inc. | Solution phase biopanning method using engineered decoy proteins |
AU2005271893A1 (en) * | 2004-07-10 | 2006-02-16 | Alexion Pharmaceuticals, Inc. | Antibodies against cancer produced using masked cancer cells as immunogen |
US7597884B2 (en) | 2004-08-09 | 2009-10-06 | Alios Biopharma, Inc. | Hyperglycosylated polypeptide variants and methods of use |
WO2006105993A2 (en) * | 2005-04-05 | 2006-10-12 | Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa | Method for shielding functional sites or epitopes on proteins |
US20090162383A1 (en) * | 2006-12-26 | 2009-06-25 | Padlan Eduardo A | Method for designing vaccines against constantly mutating pathogens |
CN102014953A (zh) * | 2008-02-21 | 2011-04-13 | 生物模仿公司 | 流感免疫原组合物 |
US9782472B2 (en) * | 2008-10-04 | 2017-10-10 | The Regents Of The University Of California | Therapeutic compositions and methods for treating HIV including identification and manipulation of particular domains associated with immunogenicity |
CA2745470C (en) * | 2008-12-02 | 2018-09-25 | Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Conicet) | Modified protozoan expressing at least two variable surface proteins (vsp), a vaccine comprising it and procedures, uses, and methods thereof |
JP2012511033A (ja) * | 2008-12-08 | 2012-05-17 | テゴファーム コーポレーション | 多価化合物の可逆阻害用マスキングリガンド |
WO2011028963A2 (en) * | 2009-09-03 | 2011-03-10 | Biological Mimetics, Inc. | Immunogenic hiv composition |
WO2011091376A2 (en) | 2010-01-24 | 2011-07-28 | Biological Mimetics, Inc. | Immunogenic influenza composition |
CA2793959C (en) | 2010-03-25 | 2019-06-04 | Oregon Health & Science University | Cmv glycoproteins and recombinant vectors |
US9512182B2 (en) | 2010-12-13 | 2016-12-06 | University Of Utah Research Foundation | Vaccine antigens that direct immunity to conserved epitopes |
CA2832109C (en) | 2011-06-10 | 2021-07-06 | Oregon Health & Science University | Cmv glycoproteins and recombinant vectors |
AU2012216792A1 (en) | 2011-09-12 | 2013-03-28 | International Aids Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies |
EP3269728B1 (en) | 2011-10-20 | 2020-12-16 | The Government of The United States of America as represented by The Secretary, Department of Health and Human Services | Dengue virus e-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes |
EP2586461A1 (en) | 2011-10-27 | 2013-05-01 | Christopher L. Parks | Viral particles derived from an enveloped virus |
EP2679596B1 (en) | 2012-06-27 | 2017-04-12 | International Aids Vaccine Initiative | HIV-1 env glycoprotein variant |
NZ704188A (en) | 2012-07-17 | 2016-04-29 | Merial Inc | Attenuated swine influenza vaccines and methods of making and use thereof |
US20150065381A1 (en) | 2013-09-05 | 2015-03-05 | International Aids Vaccine Initiative | Methods of identifying novel hiv-1 immunogens |
EP2873423B1 (en) | 2013-10-07 | 2017-05-31 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
US20170226192A1 (en) * | 2014-02-19 | 2017-08-10 | Jody Berry | Methods of modulating an immune response |
AU2015279089B2 (en) | 2014-06-26 | 2021-01-28 | Janssen Vaccines & Prevention B.V. | Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau |
ZA201608812B (en) | 2014-06-26 | 2019-08-28 | Janssen Vaccines & Prevention Bv | Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau |
US10174292B2 (en) | 2015-03-20 | 2019-01-08 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
US9931394B2 (en) | 2015-03-23 | 2018-04-03 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
EP3773698A1 (en) | 2018-04-03 | 2021-02-17 | Sanofi | Ferritin proteins |
WO2019195291A1 (en) * | 2018-04-03 | 2019-10-10 | Sanofi | Antigenic respiratory syncytial virus polypeptides |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5041376A (en) * | 1988-12-09 | 1991-08-20 | The Board Of Regents Of The University Of Texas System | Method for identifying or shielding functional sites or epitopes of proteins that enter the exocytotic pathway of eukaryotic cells, the mutant proteins so produced and genes encoding said mutant proteins |
US5585250A (en) * | 1993-08-20 | 1996-12-17 | The United States Of America As Represented By The Department Of Health & Human Services | Dampening of an immunodominant epitope of an antigen for use in plant, animal and human compositions and immunotherapies |
-
1993
- 1993-08-20 US US08/109,934 patent/US5585250A/en not_active Expired - Lifetime
-
1994
- 1994-08-19 AT AT94925937T patent/ATE211767T1/de active
- 1994-08-19 AU AU75692/94A patent/AU700786B2/en not_active Expired
- 1994-08-19 DK DK94925937T patent/DK0714444T3/da active
- 1994-08-19 WO PCT/US1994/009336 patent/WO1995006124A1/en active IP Right Grant
- 1994-08-19 ES ES94925937T patent/ES2170771T3/es not_active Expired - Lifetime
- 1994-08-19 DE DE69429625T patent/DE69429625T2/de not_active Expired - Lifetime
- 1994-08-19 CA CA002623540A patent/CA2623540A1/en not_active Abandoned
- 1994-08-19 CA CA002169764A patent/CA2169764C/en not_active Expired - Lifetime
- 1994-08-19 JP JP50766695A patent/JP3851938B2/ja not_active Expired - Lifetime
- 1994-08-19 EP EP94925937A patent/EP0714444B1/en not_active Expired - Lifetime
- 1994-08-19 PT PT94925937T patent/PT714444E/pt unknown
-
1996
- 1996-12-13 US US08/764,575 patent/US5853724A/en not_active Expired - Lifetime
-
2005
- 2005-12-21 JP JP2005367769A patent/JP2006104216A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
PT714444E (pt) | 2002-07-31 |
AU700786B2 (en) | 1999-01-14 |
CA2169764A1 (en) | 1995-03-02 |
CA2169764C (en) | 2008-04-15 |
JP3851938B2 (ja) | 2006-11-29 |
JP2006104216A (ja) | 2006-04-20 |
DK0714444T3 (da) | 2002-04-29 |
JPH09501933A (ja) | 1997-02-25 |
WO1995006124A1 (en) | 1995-03-02 |
EP0714444B1 (en) | 2002-01-09 |
DE69429625T2 (de) | 2002-09-12 |
US5585250A (en) | 1996-12-17 |
ATE211767T1 (de) | 2002-01-15 |
CA2623540A1 (en) | 1995-03-02 |
EP0714444A1 (en) | 1996-06-05 |
AU7569294A (en) | 1995-03-21 |
DE69429625D1 (de) | 2002-02-14 |
US5853724A (en) | 1998-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2170771T3 (es) | Atenuacion de un epitopo inmunodominante de un antigeno para su utilizacion en vacunas e inmunoterapias para vegetales, animales y humanos. | |
ES2184769T3 (es) | Metodos y composiciones para microencapsulacion de antigenos para utilizar como vacunas. | |
GT200300180A (es) | Vacunas para enfermedades reproductoras del ganado | |
PA8592301A1 (es) | Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos | |
CO4560552A1 (es) | Antagonistas de receptores de taquicininas no peptidicos | |
ES2152222T3 (es) | Sulfonamidas, su preparacion y su uso como medicamento e intermedio. | |
ES2182850T3 (es) | Procedimientos y composiciones para la microencapsulacion de adyuvantes. | |
AR005703A1 (es) | Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen | |
UY34901A (es) | ?monohidrato cristalino, procedimiento para su preparacion ysu utilizacion para la preparacion de un medicamento?. | |
ES2058185T3 (es) | Derivados de camptotecina y procedimiento para su preparacion. | |
AR025750A1 (es) | Vacunas | |
ES2159517T3 (es) | Grapas esteriles e instrumento para su colocacion. | |
GT199900070A (es) | Derivados de isotiazol, utiles como agentes anticancerosos. | |
AR026610A1 (es) | Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central | |
ES2080307T3 (es) | Composiciones farmaceuticas. | |
AR031283A1 (es) | Composicion y metodo de dieta para animales | |
HN2003000183A (es) | Difenilazetidinonas sustituidas en anillo procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso. | |
MX9205441A (es) | Prenda de ropa intima para sostener el busto, sin espalda. | |
AR109263A2 (es) | Composición que comprende moxidectina | |
MX9303597A (es) | Derivados de imidazopirinas, procedimiento para su preparacion preparaciones farmaceuticas que los contienen. | |
CL2020000491A1 (es) | Métodos para aumentar y/o estabilizar la función cardiaca en pacientes con enfermedad de fabry. | |
UY27725A1 (es) | Material micronizado cristalino, procedimiento para su preparación y su utilización para la preparación de un medicamento. | |
GT200200028A (es) | Compuestos de ppar | |
IT1263840B (it) | Formulazioni orali di ubidecarenone in forma di capsule | |
ES2054718T3 (es) | El uso de gepirona para la preparacion de una composicion farmaceutica para el tratamiento de la depresion atipica. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 714444 Country of ref document: ES |